Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
about
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.Cholesterol, lipid rafts, and diseaseVirus entry, assembly, budding, and membrane raftsSpecific association of glycoprotein B with lipid rafts during herpes simplex virus entryProfilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virusThe pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathiesLipids and membrane microdomains in HIV-1 replicationRestoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterolThe novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes.Leishmania donovani infection enhances lateral mobility of macrophage membrane protein which is reversed by liposomal cholesterolVisualizing lipid raft dynamics and early signaling events during antigen receptor-mediated B-lymphocyte activation.Zipper-like internalization of Dr-positive Escherichia coli by epithelial cells is preceded by an adhesin-induced mobilization of raft-associated molecules in the initial step of adhesion.Cholesterol-rich membrane microdomains mediate cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal-distending toxinLipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cellsPathogenesis of Afa/Dr diffusely adhering Escherichia coli.Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarizationMitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation.CD317/tetherin is an organiser of membrane microdomainsAssociation of the caveola vesicular system with cellular entry by filovirusesCholesterol dependence of collagen and echovirus 1 trafficking along the novel α2β1 integrin internalization pathway.Distinguishing individual lipid headgroup mobility and phase transitions in raft-forming lipid mixtures with 31P MAS NMRGag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes.The Observation of Highly Ordered Domains in Membranes with Cholesterol.The roles of membrane microdomains (rafts) in T cell activation.Role of lipid-mediated signal transduction in bacterial internalization.The interaction between amyloid-β peptides and anionic lipid membranes containing cholesterol and melatoninTannerella forsythia invasion in oral epithelial cells requires phosphoinositide 3-kinase activation and clathrin-mediated endocytosis.Transmembrane adaptor proteins: organizers of immunoreceptor signalling.The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization.GM1 clustering inhibits cholera toxin binding in supported phospholipid membranesVibrio vulnificus VvhA induces NF-κB-dependent mitochondrial cell death via lipid raft-mediated ROS production in intestinal epithelial cells.Vibrio vulnificus VvpE inhibits mucin 2 expression by hypermethylation via lipid raft-mediated ROS signaling in intestinal epithelial cellsBlocking of HIV-1 infection by targeting CD4 to nonraft membrane domains.Escherichia coli DraE adhesin-associated bacterial internalization by epithelial cells is promoted independently by decay-accelerating factor and carcinoembryonic antigen-related cell adhesion molecule binding and does not require the DraD invasin.Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranesTLR-mediated immune responses in the urinary tract.Cholesterol dependence of HTLV-I infection.Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trialMultivalent ligand-receptor binding on supported lipid bilayers.
P2860
Q24307963-5BE2FC88-D52F-409B-AF6A-5ECE3E050E87Q24553188-68BD557C-F44B-4962-BACE-7F6EA2605A20Q24673161-83DD699C-0360-465E-96A9-CE616BAC65F8Q24683262-1D9A0E0F-A811-4BF3-B20D-4A1AE2F8716BQ24800730-62D45125-083A-4BFE-8D35-6B9629890890Q27004097-854C31ED-AC61-45E6-96DA-864172CFAD43Q27489393-6A481CA5-2319-4819-8A40-41DE7662CE46Q28476834-F5CA5D59-F566-4C47-B33D-60182C39F262Q28506965-ED7BE5F0-D7A6-4A41-8358-39B5396BCCECQ28542482-F7629AA9-528D-4656-BAE0-750A8D72BB6CQ30477557-33985EA5-BF04-4097-874A-FC656B6636B9Q31080703-58B8637E-B93B-4EE4-9C3D-D463A34C2479Q33239764-50FBC154-63E0-4BC9-BC9D-A403012B9C3CQ33463351-A20B25E2-3379-490F-B649-36EA5E69702CQ33755215-56901D51-6EFA-487A-AD23-4CF5965D5C5CQ33843329-C9EF69EB-0571-4752-9E33-21C81813994BQ33933192-E4AAFB6D-06C8-4E72-93FF-B95A951F8CF7Q33939529-82E00DD7-466F-4793-98F4-3031F5E30FB0Q34325965-DCE5E44A-BB07-4325-89FA-0E4C23C12318Q34338277-726A9B10-4575-47EF-816B-E2F9FA2A0003Q34580961-FE29A248-58C7-4487-9C85-444C478D2582Q34600856-82C4A6FE-31CB-44B0-8580-AB3249C2FFACQ34648092-5EF1F3F3-D153-469C-ACD9-03FEBDECB76DQ34792593-A08C41FD-D0B5-43A0-BA29-FD56F3907A89Q35076697-4D61C708-D264-4256-90D3-60A8B5BBBEB1Q35114079-2A8681B1-8C05-4B48-B438-4E1671A25F3CQ35184913-438B9CFF-411F-4E0B-B429-0EE0CCA01EC9Q35199085-E0975487-EBF8-4D63-AFA5-4CF7A78817F7Q35852278-61BD3194-A816-4AF7-A1D0-DFEA19574B44Q36053567-9246AB0E-0E97-4735-8ADC-BCBB84F84A1BQ36329514-D3521D8B-B1E8-4458-B5CF-41919C734495Q36347273-6D459916-32B8-412F-98DF-22C94C122120Q36347340-B046C02D-902C-41A2-841E-3F779B1A6CC2Q36370878-38A7A9EA-6C21-4E1D-BF42-C340F518E755Q36845245-66082B85-4ADE-4A96-984A-7EE1C1A07A52Q37034681-5512A464-4251-44A7-B69F-1E43F3F8D0C3Q37074933-8C9FF83D-9F27-40BE-83F0-1BF7705B331DQ37163395-CA37618F-10CD-460B-AD88-58D8EF343173Q37249400-FB30CD47-20F5-4E58-A949-051C0B5875E5Q37365136-CA0E99DE-7ABE-449A-8F7C-2E0DBD00F471
P2860
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@ast
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@en
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@nl
type
label
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@ast
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@en
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@nl
prefLabel
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@ast
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@en
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@nl
P356
P1476
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.
@en
P2093
van der Goot FG
P356
10.1006/SMIM.2000.0300
P577
2001-04-01T00:00:00Z